CONMED Corporation revised earnings guidance for the full year 2022. The Company is narrowing its revenue guidance for the full year 2022 and now expects revenue between $1.1 billion and $1.115 billion compared to its prior guidance of between $1.095 billion and $1.140 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.76 USD | +2.34% | +9.09% | -34.47% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.47% | 2.21B | |
-3.79% | 184B | |
-0.84% | 108B | |
-3.75% | 67.8B | |
+3.45% | 51.05B | |
+9.04% | 44.67B | |
+3.40% | 41.78B | |
+3.66% | 26.59B | |
+3.21% | 26.78B | |
+15.23% | 25.86B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Revises Earnings Guidance for the Full Year 2022